Brian Burns

Director, New Product Planning, Oncology at Taiho Oncology, Inc.

Brian Burns has a diverse background in the pharmaceutical industry, with significant experience in oncology. Currently, they hold the position of Director of New Product Planning for Oncology at Taiho Oncology, Inc. Prior to this, they were the Director of New Product Planning for Oncology at Takeda Oncology.

Brian's oncology expertise extends back to their time at AstraZeneca, where they served as the LYNPARZA Commercial Brand Strategy Lead in US Marketing. In this role, they were responsible for developing brand strategies, creating marketing assets, conducting market research, and training field staff for product launches in metastatic breast cancer and metastatic pancreatic cancer. Brian also led the execution of a science-based HCP campaign for various types of cancer. Brian's tenure at AstraZeneca also included roles as Associate Director of New Product Planning for Oncology and Director of Global Product and Portfolio Strategy for Oncology.

Before joining AstraZeneca, Brian worked at MedImmune as an Associate Director of Global Strategic Marketing in Oncology. Brian also gained experience at ScienceFirst, LLC as an Account Director, where they managed a global oncology platform focused on engaging key opinion leaders and improving treatment outcomes for patients with malignant melanoma.

Brian's earlier career includes positions at Bristol-Myers Squibb as an Associate Director of Global Marketing in Oncology, UCB S.A. as a Director of New Product Commercialization in Oncology, Novo Nordisk A/S as an International Product Manager/Senior Portfolio Manager in Oncology, and GlaxoSmithKline as a Scientist/Senior Analyst.

Overall, Brian Burns has a proven track record in oncology product planning, brand strategy, market research, and customer engagement.

Brian Burns has a Bachelor of Science (BS) degree in Microbiology from The University of Georgia, which they obtained from 1990 to 1994. Brian then pursued a Master of Science (MS) degree in Microbiology at Georgia State University, where they studied from 1994 to 1997. Later, from 2000 to 2002, Brian attended Saint Joseph's University - Erivan K. Haub School of Business, where they earned a Master of Business Administration (MBA) with a focus on Finance.

Links

Previous companies

Bristol-Myers Squibb logo
Novo Nordisk logo
AstraZeneca logo

Timeline

  • Director, New Product Planning, Oncology

    January, 2022 - present

View in org chart